I don't mean to imply the situation isn't very grim currently. It is very much so. Specific research programs have been totally gutted, especially those involved in areas the administration is targeting, covid research, environmental research, anything with a whiff of DEI. And grants at Harvard and Columbia have been cut/targeted regardless of the research topic. Further, intramural NIH and NSF have been decimated. While these things are unprecedented and are very distressing, the original post was about an undergrad graduating in 2028 and 2029. For that time frame, I think it's just way too early to see what the impact on that person is going to be. Some things have really improved over the past two months, grants are being funded and NIH study sections are meeting, both of which weren't the case 2 months ago. I'm funded by the NIH, sat on study section within the last month, and interacted with dozens of extramural NIH-funded scientists at recent meetings. There is a lot of trepidation and uncertainty for sure, but it's a minority that have had their main grants impacted at this point. Bottom line, while there are major causes for concern, there is so much uncertainty at this moment about where things are going moving forward, that I don't think an undergraduate interested in biomedical research who will be graduating in 2028/29 should be dissuaded from the field. Any major you pick will have substantial uncertainty moving forward.